Mesoblast (MEOBF) Equity Ratio (2017 - 2022)

Mesoblast (MEOBF) has disclosed Equity Ratio for 6 consecutive years, with 0.75 as the latest value for Q2 2022.

  • Quarterly Equity Ratio fell 3.85% to 0.75 in Q2 2022 from the year-ago period, while the trailing twelve-month figure was 0.75 through Jun 2022, down 3.85% year-over-year, with the annual reading at 0.75 for FY2022, 3.85% down from the prior year.
  • Equity Ratio hit 0.75 in Q2 2022 for Mesoblast, down from 0.78 in the prior quarter.
  • In the past five years, Equity Ratio ranged from a high of 0.79 in Q2 2018 to a low of 0.74 in Q2 2019.
  • Historically, Equity Ratio has averaged 0.76 across 5 years, with a median of 0.75 in 2022.
  • Biggest five-year swings in Equity Ratio: fell 6.45% in 2019 and later grew 4.26% in 2021.
  • Year by year, Equity Ratio stood at 0.79 in 2018, then dropped by 6.45% to 0.74 in 2019, then rose by 1.51% to 0.75 in 2020, then increased by 4.26% to 0.78 in 2021, then dropped by 3.85% to 0.75 in 2022.
  • Business Quant data shows Equity Ratio for MEOBF at 0.75 in Q2 2022, 0.78 in Q2 2021, and 0.75 in Q2 2020.